Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
172.22
-5.21 (-2.94%)
Jul 2, 2025, 4:00 PM - Market closed
Tenet Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 20,520 | 20,665 | 20,548 | 19,174 | 19,485 | 17,640 | Upgrade
| |
Revenue Growth (YoY) | -1.80% | 0.57% | 7.17% | -1.60% | 10.46% | -4.54% | Upgrade
|
Cost of Revenue | 12,233 | 12,456 | 12,743 | 12,126 | 12,217 | 11,409 | Upgrade
|
Gross Profit | 8,287 | 8,209 | 7,805 | 7,048 | 7,268 | 6,231 | Upgrade
|
Selling, General & Admin | 410 | 417 | 418 | 412 | 412 | 403 | Upgrade
|
Other Operating Expenses | 3,682 | 3,756 | 3,722 | 3,310 | 3,439 | 3,402 | Upgrade
|
Operating Expenses | 4,908 | 4,991 | 5,010 | 4,563 | 4,706 | 4,662 | Upgrade
|
Operating Income | 3,379 | 3,218 | 2,795 | 2,485 | 2,562 | 1,569 | Upgrade
|
Interest Expense | -812 | -826 | -901 | -890 | -923 | -1,003 | Upgrade
|
Earnings From Equity Investments | 257 | 260 | 228 | 216 | 218 | 169 | Upgrade
|
Other Non Operating Income (Expenses) | 135 | 134 | 26 | 20 | 25 | 10 | Upgrade
|
EBT Excluding Unusual Items | 2,959 | 2,786 | 2,148 | 1,831 | 1,882 | 745 | Upgrade
|
Merger & Restructuring Charges | -88 | -95 | -94 | -132 | -77 | -198 | Upgrade
|
Gain (Loss) on Sale of Assets | 438 | 2,916 | 23 | 1 | 445 | 14 | Upgrade
|
Asset Writedown | -6 | -7 | -43 | -94 | -8 | -92 | Upgrade
|
Legal Settlements | -48 | -35 | -47 | -70 | -116 | -44 | Upgrade
|
Other Unusual Items | -326 | -317 | -370 | -191 | -238 | 246 | Upgrade
|
Pretax Income | 2,929 | 5,248 | 1,617 | 1,345 | 1,888 | 671 | Upgrade
|
Income Tax Expense | 577 | 1,184 | 306 | 344 | 411 | -97 | Upgrade
|
Earnings From Continuing Operations | 2,352 | 4,064 | 1,311 | 1,001 | 1,477 | 768 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | -1 | - | Upgrade
|
Net Income to Company | 2,352 | 4,064 | 1,311 | 1,001 | 1,476 | 768 | Upgrade
|
Minority Interest in Earnings | -897 | -864 | -700 | -590 | -562 | -369 | Upgrade
|
Net Income | 1,455 | 3,200 | 611 | 411 | 914 | 399 | Upgrade
|
Net Income to Common | 1,455 | 3,200 | 611 | 411 | 914 | 399 | Upgrade
|
Net Income Growth | -44.44% | 423.73% | 48.66% | -55.03% | 129.07% | - | Upgrade
|
Shares Outstanding (Basic) | 96 | 97 | 102 | 107 | 107 | 105 | Upgrade
|
Shares Outstanding (Diluted) | 96 | 98 | 105 | 111 | 109 | 106 | Upgrade
|
Shares Change (YoY) | -6.73% | -6.60% | -5.17% | 1.79% | 2.17% | 2.77% | Upgrade
|
EPS (Basic) | 15.22 | 33.02 | 6.01 | 3.84 | 8.56 | 3.80 | Upgrade
|
EPS (Diluted) | 15.09 | 32.70 | 5.71 | 3.78 | 8.42 | 3.75 | Upgrade
|
EPS Growth | -40.16% | 473.12% | 50.87% | -55.07% | 124.49% | - | Upgrade
|
Free Cash Flow | 1,412 | 1,116 | 1,623 | 321 | 910 | 2,867 | Upgrade
|
Free Cash Flow Per Share | 14.63 | 11.40 | 15.49 | 2.90 | 8.38 | 26.98 | Upgrade
|
Gross Margin | 40.38% | 39.72% | 37.98% | 36.76% | 37.30% | 35.32% | Upgrade
|
Operating Margin | 16.47% | 15.57% | 13.60% | 12.96% | 13.15% | 8.89% | Upgrade
|
Profit Margin | 7.09% | 15.48% | 2.97% | 2.14% | 4.69% | 2.26% | Upgrade
|
Free Cash Flow Margin | 6.88% | 5.40% | 7.90% | 1.67% | 4.67% | 16.25% | Upgrade
|
EBITDA | 4,195 | 4,036 | 3,665 | 3,326 | 3,417 | 2,426 | Upgrade
|
EBITDA Margin | 20.44% | 19.53% | 17.84% | 17.35% | 17.54% | 13.75% | Upgrade
|
D&A For EBITDA | 816 | 818 | 870 | 841 | 855 | 857 | Upgrade
|
EBIT | 3,379 | 3,218 | 2,795 | 2,485 | 2,562 | 1,569 | Upgrade
|
EBIT Margin | 16.47% | 15.57% | 13.60% | 12.96% | 13.15% | 8.89% | Upgrade
|
Effective Tax Rate | 19.70% | 22.56% | 18.92% | 25.58% | 21.77% | - | Upgrade
|
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.